SUBSCRIBE
SUBSCRIBE
News   FDA

GlaxoSmithKline Gets Formal EU Okay for Breast Cancer Drug

June 12, 2008 | 
1 min read
LONDON, June 12 (Reuters) - GlaxoSmithKline Plc has received formal European marketing authorization for its new breast cancer pill Tyverb, the world's second biggest drugmaker said on Thursday.
FDA Approvals Europe
GlaxoSmithKline
MORE ON THIS TOPIC
Hands holding crystal ball fortune telling collage art. Abstract concept of prophecy and prediction of future illustration
FDA
Krystal Biotech’s FDA Platform Designation Pushes Limits of the Award
October 21, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Hand holding a lung shape symbol against a blue background. World tuberculosis day, world no tobacco day, lung cancer, pulmonary hypertension, pneumonia
Lung cancer
Summit Eyes 2025 FDA Application for Ivonescimab Despite Overall Survival Miss
October 21, 2025
 · 
2 min read
 · 
Tristan Manalac
World kidney day. Human hands holding healthy kidney shape made from paper on light blue background.
Autoimmune disease
Roche’s Gazyva Expands Out of Cancer With FDA Approval for Lupus
October 20, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
The white plane flies against the blue sky, leaving a white trail. Vector illustration
FDA
Replimune Soars Upon FDA Resubmission for Advanced Melanoma Drug
October 20, 2025
 · 
2 min read
 · 
Heather McKenzie